GH Secretagogue Peptides
Tesamorelin
6mgC₂₂₁H₃₆₆N₇₂O₆₇S
Key Research Findings
- Characterisation of the trans-3-hexenoic acid N-terminal modification.
- Published pituitary cell-line studies on GH-secretion-pathway activity.
- Pharmacokinetic profile reported in animal-model studies.
Overview
Tesamorelin is a synthetic 44-residue analogue of GHRH with an N-terminal trans-3-hexenoic acid modification. Supplied as a lyophilised powder for in-vitro research use only.
Mechanism of Action
Reported in published in-vitro studies as a GHRH-receptor ligand active on pituitary somatotroph cell-line assays. Not intended for human or veterinary use.
Research Effects
GHRH-Receptor Binding
Extensive ResearchReported in receptor-binding assays as a high-affinity ligand of the pituitary GHRH receptor.
Somatotroph Cell Assays
Extensive ResearchPublished in-vitro studies in pituitary cell models report effects on GH-secretion-pathway activity.
Stability Profile
Moderate ResearchN-terminal modification characterised in published studies as conferring improved plasma stability.
Laboratory Research Only — All information on this page is provided for scientific research purposes only. This is a certified reference material sample sold and distributed for laboratory research only.
Quick Facts
Research Status Key
Related Peptides
GH Secretagogue Peptides
CJC-1295 (No DAC)
CJC-1295 (No DAC) is a synthetic 29-residue analogue of growth-hormone-releasing hormone (GHRH), without the Drug Affinity Complex linker. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
GH Secretagogue Peptides
Ipamorelin
Ipamorelin is a synthetic pentapeptide ghrelin-receptor (GHSR-1a) agonist. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →
GH Secretagogue Peptides
GHRP-6
GHRP-6 is a synthetic hexapeptide ghrelin-receptor (GHSR-1a) agonist of the first-generation GHRP class. Supplied as a lyophilised powder for in-vitro research use only.
Learn More →